Philip Newsome is Director of the Innovate-UK funded Midlands and Wales Advanced Therapy Treatment Centre as well as Professor of Experimental Hepatology and Director of the Centre for Liver and Gastrointestinal Research.
He is Deputy Director of the NIHR Birmingham Biomedical Research Centre and is the Chief Investigator on the EU FP7 funded MERLIN project as well as the Innovate UK funded POLARISE trial looking at mesenchymal stromal cells in liver disease.
Phillip is an enthusiastic communicator on the theme of translational cell therapy work and non-alcoholic fatty liver disease (NAFLD) which is the commonest cause of liver disease in the West, and for which there are no effective therapies. He runs the metabolic services at the Liver Unit at the Queen Elizabeth Hospital Birmingham which includes a large multi-disciplinary clinic for patients with NAFLD.
His work has also been in Stem/stromal cell biology, exploring the trafficking and role of both adult and embryonic stem cells in the context of liver injury. This research has allowed identification of the key molecular interactions that regulate the successful engraftment of such cells into the liver.
Philip has published over 150 major research papers in scientific journals as well as reviews and book chapters in the fields of stromal cell biology and liver disease. He has received major grants from Innovate UK, NIHR, European Commission, Wellcome Trust, UKSCF, BBSRC and the Medical Research Council.